MAIA Biotechnology, Inc.
MAIA
$2.46
$0.125.13%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.57M | -2.74M | -8.88M | -8.07M | -6.26M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -563.30K | -775.90K | 5.58M | 4.54M | 1.35M |
| Change in Net Operating Assets | 227.10K | -12.80K | -1.39M | -62.10K | 916.80K |
| Cash from Operations | -3.91M | -3.52M | -4.68M | -3.59M | -3.99M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.98M | 690.60K | 8.31M | 4.99M | 5.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -134.20K | -63.80K | -320.30K | -276.90K | -641.60K |
| Cash from Financing | 4.85M | 626.80K | 7.99M | 4.72M | 5.03M |
| Foreign Exchange rate Adjustments | -26.80K | 9.30K | 5.40K | -9.50K | 13.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 910.50K | -2.89M | 3.31M | 1.12M | 1.05M |